前往化源商城

Journal of Medicinal Chemistry 2003-02-13

Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity.

Reeti Katoch-Rouse, Olga A Pavlova, Tara Caulder, Alexander F Hoffman, Alexey G Mukhin, Andrew G Horti

文献索引:J. Med. Chem. 46 , 642-645, (2003)

全文:HTML全文

摘要

Exploration of the central CB1 cannabinoid receptors using positron emission tomography (PET) will allow for an understanding of the pharmacological and physiological role played by these receptors in the CNS. Current tracers are highly lipophilic compounds that exhibit very high nonspecific to specific binding ratios and as a result are inapt for use in humans. We have synthesized a series of less lipophilic analogues of SR141716 to serve as potential radioligands. Binding affinities of the series and a functional electrophysiological assay of three of our compounds have been presented.

相关化合物

结构式 名称/CAS号 全部文献
1-(2,4-二氯苯基)-5-(4-甲氧基苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺 结构式 1-(2,4-二氯苯基)-5-(4-甲氧基苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺
CAS:502486-89-7